Why Galapagos (GLPG) Could Be Positioned for a Surge?
Zacks
Zacks Equity Research
ZacksDecember 29, 2016
Galapagos NV GLPGis a Medial-Biomedical and Genetics company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on GLPG’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Galapagos could be a solid choice for investors.
Current Quarter Estimates for GLPG
In the past 30 days, 2 estimates have gone higher for Galapagos while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates narrowing from loss of 38 cents a share 30 days ago, to earnings of 25 cents, a significant move.
Current Year Estimates for GLPG
GALAPAGOS -ADR Price and Consensus
GALAPAGOS -ADR Price and Consensus | GALAPAGOS -ADR Quote
Meanwhile, Galapagos’s current year figures are also looking quite promising, with 1 estimate moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, narrowing from loss of 80 cents per share 30 days ago to loss of 16 cents per share today, an increase of 80%